has not shown increased phosphorylation. The purpose of this study was to establish a neuronal model system in which the phosphorylation of R406W tau is increased and thus more representative of the in vivo situation. To accomplish this goal immortalized mouse cortical cells that express low levels of endogenous tau were stably transfected with human wild type or R406W tau. In this neuronal model R406W tau was more highly phosphorylated at numerous epitopes, and showed decreased microtubule binding compared to wild type tau, an effect that could be reversed by dephosphorylation. In addition the expression of R406W tau in the cortical cells resulted in increased cell death as compared to wild type tau expressing cells when the cells were exposed to an apoptotic stressor. These results indicate that in an appropriate cellular context R406W tau is hyperphosphorylated, which leads to decreased microtubule binding. Further, expression of R406W tau sensitized cells to apoptotic stress, which may contribute to the neuronal cell loss that occurs in this FTDP-17 tauopathy.
INTRODUCTION
Frontotemporal dementia (FTD) 1 refers to a group of neurological disorders that are characterized clinically by progressive behavioral changes and neuropathologically by neuronal loss in the frontal and temporal lobes and the presence of filamentous deposits of abnormally hyperphosphorylated tau protein in neurons and/or glial cells (1) (2) (3) (4) . FTD's occur mainly as sporadic cases but also as familial forms with an autosomal dominant mode of inheritance and age dependent penetrance (1) . In 1998 it was demonstrated that several familial frontotemporal dementias were due to mutations in the tau gene, and have been referred to as Frontotemporal Dementia and Parkinsonism linked to Chromosome 17 (FTDP-17) (5-7). Since these initial discoveries additional tau mutations have been described in frontotemporal dementia families and presently over 25 mutations in the tau gene have been identified (8, 9) . They include missense mutations in coding regions, amino acid deletions and intronic mutations in the region following exon 10. The mutations maybe divided into two main groups -those that affect alternative splicing of exon 10 leading to changes in the ratio of tau mRNAs +/-exon 10, and thus the proportion of tau with 3 microtubule binding repeats versus tau with 4 microtubule binding repeats; and missense mutations.
Tau is a microtubule-associated protein that facilitates microtubule assembly and stabilization (for review see (2)). Alternative splicing of the tau gene generates the six tau isoforms that occur in adult human brain (10, 11) . The tau isoforms differ by the presence of three or four carboxy-terminal repeats due to the splicing in or out of exon 10, which are involved in microtubule binding, and zero, one or two amino-terminal inserts whose functions are still unknown (11, 12) . The function of tau is negatively by guest on http://www.jbc.org/ Downloaded from 4 regulated by site-specific phosphorylation (13, 14) and in FTDP-17 brain tau is hyperphosphorylated and non-functional (3, 15) .
In vitro studies have shown that many of the FTDP-17 missense mutations likely impair the ability of tau to bind to microtubules (16) (17) (18) (19) . The mutations can also impair the ability of tau to stimulate the formation of microtubules by increasing the lag time and reducing the rate of polymerisation (16, 17, 19) . However, this data is not unequivocal since identical in vitro assays have given differing results (16, 19) , and there is some discussion as to the extent to which the FTDP-17 missense mutations affect tau-microtubule interactions (18, 20) . The effects of the FTDP-17 mutations on tau's ability to interact with microtubules and affect microtubule function in situ have also been examined with variable outcomes being reported (21) (22) (23) . It should be noted that the majority of these previous studies were carried out using either cell free systems or non-neuronal cells that had been transiently transfected with wild type or FTDP-17 mutant tau constructs (16, (19) (20) (21) (22) (23) (24) .
The nature of the neuronal loss seen in FTDP-17 cases is still unknown.
Furukawa and co-workers showed that the N279K and V337M tau mutations sensitized transfected SH-SY5Y cells to apoptotic death compared to wild type tau expressing cells (25) . Further, using a microarray technique to examine gene expression in a P301L tau mouse model of FTDP-17 it was reported that there was decreased expression of anti-apoptotic genes and altered expression of trafficking proteins (26) , suggesting that apoptosis is occurring. This P301L tau mouse model showed evidence of gliosis and neuronal loss primarily in the brain stem and spinal cord (27) . Further, another P301L tau transgenic mouse expressing the longest tau isoform also showed by guest on November 6, 2017
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cases have yet to be elucidated.
The FTDP-17 R406W tau mutation has been described in an American, a Dutch and a Japanese family (30) (31) (32) . Neuropathological examination showed neuronal loss in the frontal and temporal lobes and the presence of neurofibrillary tangles and neuropil threads throughout the brains (30) (31) (32) . Interestingly, it was found that the morphological and biochemical characteristics of the tau filaments with the R406W mutation appeared indistinguishable from those found in Alzheimer's disease brains (19, 31, 33) . In one report tau with the R406W mutation did not bind microtubules or promote microtubule assembly as effectively as wild type tau or the other FTDP-17 mutant tau's that were examined (19) . However in two other studies R406W mutant tau was found to be more efficient at promoting microtubule assembly than the other FTDP-17 tau mutants (16, 18) . Therefore the effects of the R406W tau mutation on microtubule binding and function remain to be fully established. In addition, stable or transient transfection of R406W tau into non-neural cell lines has resulted in R406W tau being less phosphorylated than the wild type tau (23, 34) , even though the tau from R406W FTDP-17 cases is hyperphosphorylated (30, 31) .
In this study we have used a novel model system to elucidate the effects of the SDS, 10 mM EGTA, 10 mM EDTA, 25 mM dithiothreitol, 10% glycerol, 0.01% bromophenol blue), incubated in a boiling water bath for 5 min, electrophoresed on 10% SDS polyacrylamide gels, transferred to nitrocellulose membrane and probed with the indicated antibodies. The tau antibodies used in this study were Tau5 and 5A6 (Tau5 from Dr. L. Binder) which are phospho-independent tau antibodies (37,38), Tau-1 (from Dr. L. Binder), which recognizes tau only when Ser195, Ser198, Ser199, Ser202, and Thr205 (numbered according to the longest human brain tau isoform (10)) are not phosphorylated (39, 40) , PHF-1 (from Dr. P. Davies), which recognizes tau phosphorylated at Ser396/404 (41) and AT180 (Endogen), which recognizes tau phosphorylated at Thr231 (42, 43 ). An antibody to β-actin (Chemicon) was also used.
After incubating with the appropriate horseradish peroxidase-conjugated secondary for up to 4 hr as described previously (46) . Cells were collected at the indicated time points and used for immunoblotting or the caspase 3 assay.
Caspase 3 assay
At the indicated times post sorbitol treatment, cells were collected and used to measure caspase 3 activity as previously described (47) .
In vitro microtubule binding assay
The microtubule binding assay was carried out as previously described (48) . Unbound (supernatant) and microtubule bound (pellet) fractions were electrophoresed on a 10%
SDS polyacrylamide gel, transferred to nitrocellulose membrane and probed with the total tau antibodies Tau5/5A6. Following incubation, microtubules were added to 30 µl of the reaction mix (equivalent to 15 µg of whole cell lysate) and the microtubule binding assay was carried out as described above. Microtubule bound (pellet) fractions were electrophoresed on an 8%
SDS polyacrylamide gel, transferred to nitrocellulose membrane and probed with the total tau antibodies Tau5/5A6.
Cellular fractionation
Cells were separated into soluble and cytoskeletal insoluble fractions as described previously (49) with a few modifications. Cells were rinsed with pre-warmed PBS and collected in 100 µl PBS. Cells were spun and the resulting pellet was resuspended in 40
µl of pre-warmed extraction buffer [80 mM Pipes, (pH 6.8), 1 mM MgCl 2 , 2 mM EGTA, 0.1 mM EDTA, 0.1% Triton-X100, 30% glycerol] containing a protease inhibitor cocktail (Sigma) and a phosphatase inhibitor (0.5 µM okadaic acid). Lysate was incubated at 37°C for 8 min prior to centrifugation (15 min at 15000 X g and 25°C). Equal amounts of pellet and supernatant fraction were electrophoresed and processed for immunodetection with anti-tau antibodies as described above.
Statistics
All data were analysed using ANOVA. The values were considered significantly different when P < 0.05. Results were expressed as mean ± SEM. could not be readily detected (Fig. 2) . The R406W mutant tau expressed in the CN1.4
cortical cells was more highly phosphorylated at both the PHF-1 (tau phosphorylated at Ser396/404) and Tau-1 sites (Tau-1 recognizes tau only when Ser195, Ser198, Ser199, Ser202, and Thr205 are not phosphorylated) compared to wild type tau (Fig. 2) .
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Cytoskeletal association of wild type and R406W mutant tau in stably transfected
CN1.4 cortical cells
Since the mutant R406W tau was in an increased phosphorylation state, the extent of interaction of wild type and mutant R406W tau with the neural cytoskeleton was assessed. Cell lysates were separated into soluble and insoluble cytoskeletal fractions and immunoblotted. Wild type tau was distributed evenly between the soluble supernatant and cytoskeletally insoluble pellet fractions but mutant R406W tau was localised almost exclusively in the soluble fraction (Fig. 3) . Additionally, mutant R406W tau in the soluble fraction was more highly phosphorylated at the Tau-1, PHF-1 and AT180 sites (tau phosphorylated at Thr231) compared to wild type tau (Fig. 3 ),
indicating that mutant R406W tau is more phosphorylated and less associated with the neuronal cytoskeleton. It is interesting to note that AT180 immunoreactivity is only observed in the soluble fraction from the R406W mutant tau expressing cells given that phosphorylation of Thr231 likely plays a key role in decreasing tau's association with microtubules (48).
Mutant R406W tau does not efficiently bind microtubules
To determine the microtubule binding capacity of FTDP-17 mutant R406W tau a microtubule binding assay was carried out. High speed supernatants from wild type and R406W mutant tau expressing CN1.4 cells were incubated with taxol-stabilized microtubules, and the amount of tau bound to the microtubules in the pellet and the amount of tau that remained unbound was measured. Wild type tau was found primarily in the microtubule-bound pellet, but R406W mutant tau was enriched in the unbound by guest on November 6, 2017
http://www.jbc.org/ Downloaded from 14 supernatant (Fig. 4B) . Total tau expression levels were also evaluated in cell lysates prepared from wild type and mutant R406W stably transfected CN1.4 cortical cells prior to use in the microtubule-binding assay and found to be equivalent (Fig. 4A) . These results indicate that mutant R406W tau does not bind microtubules as efficiently as wild type tau.
Dephosphorylation of R406W mutant tau restores its ability to bind microtubules efficiently
Since the R406W mutant tau was in an increased phosphorylation state and did not bind microtubules as efficiently as wild type tau, we wanted to determine if the microtubule binding ability of R406W mutant tau could be restored by dephosphorylation. Treatment with lambda protein phosphatase resulted in a dephosphorylation of wild type and R406W mutant tau as indicated by the increased electrophoretic mobility shift of the tau immunoreactive bands (Fig. 5A) . Additionally, dephosphorylation of R406W mutant tau resulted in a change in presentation of the tau band from a doublet to a single immunoreactive band (Fig. 5A) . Dephosphorylation of R406W mutant tau with lambda protein phosphatase almost fully restored the microtubule binding capacity of R406W mutant tau, as dephosphorylated wild type and R406W mutant tau showed equivalent microtubule binding (Fig. 5B ). Densitometric analysis indicated that for equivalent amounts of input tau there was a two fold increase in the amount of microtubule bound R406W mutant tau following dephosphorylation with lambda protein phosphatase, whilst the amount of wild type tau that was bound in the absence or presence of lambda protein phosphatase treatment remained the same. 
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These results indicate that dephosphorylation of R406W mutant tau greatly increased its ability to efficiently bind microtubules.
Cellular localisation of wild type and mutant R406W tau
To determine the intracellular localisation of wild type and R406W mutant tau, cells were grown on poly-D-lysine coated coverslips and examined immunocytochemically.
Untransfected CN1.4 cells had undetectable levels of tau, but the cytoplasmic microtubule network was evident after immunostaining with an anti-tubulin antibody (red in Fig. 6 ). The immunostaining with the anti-tau antibody was intense in the wild type tau expressing CN1.4 cortical cells (green in Fig. 6 ). Tau was present throughout the cell body and extended into the cell processes (neurites). Co-localisation of tau and tubulin was readily observed (yellow in Fig. 6 ). CN1.4 cortical cells expressing mutant R406W
tau exhibited an altered tau distribution compared to wild type tau expressing cells. The R406W tau expressing cells had a more stellate appearance with short projections and tau immunostaining was predominantly perinuclear (green in Fig. 6 ). Further, compared to wild type tau, mutant R406W tau did not show a total co-localisation with the tubulin network (merge Fig. 6 ).
Increased caspase 3 activity in R406W mutant tau expressing CN1.4 cortical cells
To determine if R406W mutant tau could sensitise CN1. (Fig. 8) . The quantitated data is shown in the bar graphs below each panel of blots (Fig. 8 ). In addition, there was evidence of tau degradation in the R406W mutant tau expressing CN1.4 cortical cells following osmotic stress treatment (Fig. 8) .
DISCUSSION
The purpose of this study was to establish a cellular model system in which R06W mutant tau exhibited characteristics of tau with the R406W mutation in the human Further, the microtubule binding capacity of R406W mutant tau expressed in cortical cells is impaired, but this loss of microtubule binding was reversed or "rescued" by dephosphorylating the tau. Additionally, we showed that R406W mutant tau exerts a cytotoxic effect in cortical cells when the cells were exposed to an apoptotic stimulus.
Tau is known to be involved in process formation and neurite extension. 18 capacity may not have been as affected (24) . Additionally, in the cortical cells the R406W mutant tau showed a predominantly perinuclear localization, and a previous report showed a similar distribution for V337M mutant tau when it was expressed in COS cells (21) . Interestingly, V337M mutant tau has also been reported to be less phosphorylated than wild type tau when expressed in neuroglioma cells, except for the PHF-1 site that was more phosphorylated (55).
Previously reported cell models of the R406W mutation have not been successful at reproducing the increased phosphorylation observed in vivo (22, 23, 34, 55) . A possible explanation for this could simply be due to using non-neuronal cells such as CHO and COS-1 (22-24,34). However, R406W mutant tau also was in a lower phosphorylation state than wild type tau when expressed in more neural-like cell systems such as neuroglioma cells (55) and neuroblastoma cells (20) . Interestingly, the one reported R406W mutant transgenic mouse model did show evidence of hyperphosphorylated tau inclusions in forebrain neurons (56) . Therefore, it can be hypothesized that immortalized mouse cortical cells provide the appropriate cellular context for increases in R406W mutant tau phosphorylation to occur and thus model this feature of FTDP-17.
It has been proposed that the FTDP-17 missense mutations that affect taumicrotubule interactions, such as the R406W mutation, exert a pathogenic effect by a partial loss of function i.e. a reduced ability to bind microtubules (57) . In vitro studies have clearly demonstrated that the tau mutations reduce, but do not abolish, the ability of tau to promote microtubule assembly (16, 18, 19) , and we have confirmed this finding in situ in our R406W mutant tau CN1.4 cortical cell model. Additionally, we have shown that if R406W mutant tau is dephosphorylated, microtubule binding is increased to (18), it is not surprising that dephosphorylating R406W mutant tau increases its ability to bind microtubules. These findings would imply that the primary reason that mutant R406W tau does not efficiently bind microtubules is because it is hyperphosphorylated.
The mechanism leading to the increased phosphorylation state of R406W mutant tau is unknown. One possibility is that the mutation in tau results in a conformational change which increases its association with protein kinases or decreases protein phosphatase binding. Because glycogen synthase kinase 3β (GSK3β) is a predominant tau kinase (58), we examined the interaction of R406W mutant tau and GSK3β. But coimmunoprecipitation studies did not reveal any differences in the interaction of wild type or R406W mutant tau with GSK-3β (data not shown), although increased phosphorylation at Thr231, a primed GSK3β site that negatively impacts microtubule binding (48, 59) , was observed for R406W tau. Goedert et al., reported that FTDP-17 mutant tau, including the R406W mutant, showed a decreased ability to bind protein phosphatase 2A (PP2A), a major tau phosphatase (60). So the increased phosphorylation state of R406W mutant tau in the cortical cell model could be due to a decreased association with PP2A. Indeed, it is clear that PP2A can efficiently dephosphorylate sites that are phosphorylated by GSK3β on other proteins (61).
The exact nature of the cell death observed in FTDP-17 tauopathies has not been determined. Animal models of the P301L tau mutation have shown gliosis, astrocytosis and neuronal apoptosis (27, 28) . A pro-apoptotic effect of N279K and V337M mutant tau Microtubule bound tau was determined by immunoblot analysis using the phosphoindependent and total tau antibodies Tau5/5A6. Dephosphorylation of R406W mutant tau restores its ability to bind microtubules to almost the levels observed for WT tau. 
